Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Pain
Interventions: DRUG: Capecitabine|DRUG: Celecoxib|PROCEDURE: Radiation Therapy|DRUG: Placebo
Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)|Pfizer